drugset / Trial / NCT00820014
Ocular Biodistribution Study for Topically Applied ESBA105
RandomizedParallel-groupQuadruple-blind
Summary
The purpose of this study is to determine whether ESBA105, a single-chain (scFv) antibody against TNF-alpha, efficiently penetrates into the anterior chamber and the vitreous body upon topical administration to the eye.
Timeline
- Start
- 2009-01
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ESBA105 | Monoclonal antibody | — | Topical |